Treat to target for osteoporosis: another step forward.


Monitoring treatment effects can inform both the physician and patient whether the medication has achieved its anticipated targets. There are several variances between patients cohorts included in clinical trials and subjects managed in standard clinical setting. Therefore, defining a patient as a "responder" or "non-responder" to management might not be… (More)